Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Substance Abuse Treatment Market Snapshot
2.2 Global Substance Abuse Treatment Market, by Treatment, 2016 (US$ Bn)
2.3 Global Substance Abuse Treatment Market Share, by Geography, 2016 (Value )
Chapter 3 Substance Abuse Treatment Market Analysis
3.1 Global Substance Abuse Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Higher Number Of Addicted Population
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance In Some Region
3.2.3 Opportunities
3.2.3.1 Increasing Treatment Awareness
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Substance Abuse Treatment Market
Chapter 4 Global Substance Abuse Treatment Market, by Treatment
4.1 Overview
4.2 Alcohol Addiction Treatment
4.3Nicotine Addiction Treatment
4.4 Drug Abuse Treatment
Chapter 5 Global Substance Abuse Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa
Chapter 6 Company Profiles
6.1 Alkermes Plc.
6.2 Allergan
6.3 Forest Laboratories, Inc.
6.4 GlaxoSmithKline Plc.
6.5 Mylan Laboratories
6.6 Pfizer Inc.
6.7 Purdue Pharma LP
6.8 Reckitt Benckiser Pharmaceuticals
6.9 Teva Pharmaceuticals
List of Figures
FIG. 1 Substance Abuse Treatment Market: Research Methodology
FIG. 2 Global Substance Abuse TreatmentMarket, by Treatment, 2016 (US$ Mn)
FIG. 3 Global Substance Abuse TreatmentMarket, by Geography, 2016 (US$ Mn)
FIG. 4 Attractive Investment Proposition, 2016
FIG. 5 Competitive Analysis of Key Players in Substance Abuse Treatment Market
FIG. 6 Global Disulfiram Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 7 Global Acamprosate Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 Global Naltrexone Market in Alcohol Addiction Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Global Nicotine Patch Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Global Nicotine Gum Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Global Nicotine Lozenge Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Global Nicotine Spray Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Global Nicotine Inhaler Market in Nicotine Replacement Treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Global Bupropion Market in Non-Nicotine Medication, 2015 – 2025 (US$ Mn )
FIG. 15 Global Varenicline Market in Non-Nicotine Medication, 2015 – 2025 (US$ Mn )
FIG. 16 Global Methadone Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn)
FIG. 17 Global Buprenorphine Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn )
FIG. 18 Global Naltrexone Market in Drug Abuse Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Substance Abuse Treatment Market Share Analysis, By Geography, 2016 vs 2025 (Value %)
FIG. 20 North America (U.S., Canada and Mexico): Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 21 U.S. Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 22 Canada Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 23 Europe (Western, Central, Eastern and South Eastern): Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 24 U.K. Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 25 Germany Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 26 Germany: Number of Clients Entering Substance Abuse Treatment, 2010-2013
FIG. 27 Rest of Europe Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 28 Asia: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 29 China Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 30 Japan Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Asia Pacific Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 32 Latin America and Caribbean: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 33 Latin America Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 Africa: Number of People in Treatment for Drug Use, Including People in Treatment for the First Time, by Drug Type and Region, 2014
FIG. 35 Middle East and Africa Substance Abuse Treatment Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Substance Abuse Treatment Market, by Treatment, 2015-2025 (US$ Mn)
TABLE 2 Global Alcohol Addiction Treatment Market, 2015-2025 (US$ Mn)
TABLE 3 Global Nicotine Addiction Treatment Market, 2015-2025 (US$ Mn)
TABLE 4 Global Drug Abuse Treatment Market, 2015-2025 (US$ Mn)
TABLE 5 Global Substance Abuse Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 North America Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 8 Europe Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 10 Asia Pacific Substance Abuse Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 12 Latin America Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 13 Middle East and Africa Substance Abuse Treatment Market, by Treatment Type, 2015-2025 (US$ Mn)
TABLE 14 Alkermes Plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 15 Allergan plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 Mylan N.V.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Pfizer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Purdue Pharma LP: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Indivior PLC: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)